Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700195 | Clinical Oncology | 2006 | 6 Pages |
Abstract
Overall outcome of patients in whom ICRT was not given remains less than satisfactory. Response to EBRT emerged as the most important factor to predict all clinical outcomes. To improve upon the dismal results of EBRT alone, we will have to decrease the OTT and consider concurrent chemo-radiation with cisplatin.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
E.P. Saibishkumar, F.D. Patel, S.C. Sharma, G. Karunanidhi, A.S. Sankar, I. Mallick,